Literature DB >> 10749563

Umbilical cord blood: an expandable resource.

M A Moore1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10749563      PMCID: PMC382860          DOI: 10.1172/JCI9094

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  14 in total

1.  Ex vivo expansion of cord blood-derived stem cells and progenitors.

Authors:  M A Moore; I Hoskins
Journal:  Blood Cells       Date:  1994

2.  I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.

Authors:  M Fischer; J Goldschmitt; C Peschel; J P Brakenhoff; K J Kallen; A Wollmer; J Grötzinger; S Rose-John
Journal:  Nat Biotechnol       Date:  1997-02       Impact factor: 54.908

3.  Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.

Authors:  T Ueda; K Tsuji; H Yoshino; Y Ebihara; H Yagasaki; H Hisakawa; T Mitsui; A Manabe; R Tanaka; K Kobayashi; M Ito; K Yasukawa; T Nakahata
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1.

Authors:  D Y Jo; S Rafii; T Hamada; M A Moore
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

5.  Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood.

Authors:  W Piacibello; F Sanavio; L Garetto; A Severino; D Bergandi; J Ferrario; F Fagioli; M Berger; M Aglietta
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

6.  The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow.

Authors:  A Peled; V Grabovsky; L Habler; J Sandbank; F Arenzana-Seisdedos; I Petit; H Ben-Hur; T Lapidot; R Alon
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.

Authors:  W Piacibello; F Sanavio; A Severino; A Danè; L Gammaitoni; F Fagioli; E Perissinotto; G Cavalloni; O Kollet; T Lapidot; M Aglietta
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

8.  Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.

Authors:  H E Broxmeyer; G Hangoc; S Cooper; R C Ribeiro; V Graves; M Yoder; J Wagner; S Vadhan-Raj; L Benninger; P Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

9.  Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand.

Authors:  Y Ohmizono; H Sakabe; T Kimura; S Tanimukai; T Matsumura; H Miyazaki; S D Lyman; Y Sonoda
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

10.  Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.

Authors:  S Tajima; K Tsuji; Y Ebihara; X Sui; R Tanaka; K Muraoka; M Yoshida; K Yamada; K Yasukawa; T Taga; T Kishimoto; T Nakahata
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.